Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma

World Journal of Gastroenterology

Volumn 21, Issue 4, 2015, Pages 1243-1250

  Zhang, Ling Qiang ^a   Xu, Xin Sen ^a   Wan, Yong ^a   Song, Si Dong ^a   Wang, Rui Tao ^a   Chen, Wei ^a   Wang, Zhi Xin ^a   Chang, Hu Lin ^a   Wei, Ji Chao ^a   Dong, Ya Feng ^b   Liu, Chang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen receptor 1; Gallbladder carcinoma; Vascular endothelial growth factor A

Indexed keywords

ESTROGEN RECEPTOR ALPHA; VASCULOTROPIN A; ESTROGEN RECEPTOR ALPHA, HUMAN; TUMOR MARKER; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLECYSTECTOMY; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIMARY TUMOR; PROGNOSTIC ASSESSMENT; PROTEIN EXPRESSION; SEX DIFFERENCE; SURGICAL MORTALITY; SURVIVAL RATE; TUMOR DIFFERENTIATION; CARCINOMA; CHEMISTRY; CHI SQUARE DISTRIBUTION; GALLBLADDER NEOPLASMS; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

BIOMARKERS, TUMOR; CARCINOMA; CHI-SQUARE DISTRIBUTION; ESTROGEN RECEPTOR ALPHA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921760365     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i4.1243     Document Type: Article

References (26)

1. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 349-364 [PMID: 11760569 DOI: 10.3322/canjclin.51.6.349]
2. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol 2012; 21: e183-e191 [PMID: 23025910 DOI: 10.1016/j.suronc.2012.08.002]
3. Alvaro D, Alpini G, Onori P, Perego L, Svegliata Baroni G, Franchitto A, Baiocchi L, Glaser SS, Le Sage G, Folli F, Gaudio E. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 2000; 119: 1681-1691 [PMID: 11113090]
4. Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A, Alpini G, Mancino MG, Attili AF, Gaudio E. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 2002; 36: 297-304 [PMID: 12143037 DOI: 10.1053/jhep.2002.34741]
5. DeMorrow S. Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation. Dig Liver Dis 2009; 41: 164-165 [PMID: 19112054 DOI: 10.1016/j.dld.2008.11.005]
6. Sica V, Nola E, Contieri E, Bova R, Masucci MT, Medici N, Petrillo A, Weisz A, Molinari AM, Puca GA. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 1984; 44: 4670-4674 [PMID: 6467220]
7. Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007; 9: R6 [PMID: 17239243 DOI: 10.1186/bcr1639]
8. Fisher RI, Neifeld JP, Lippman ME. Oestrogen receptors in human malignant melanoma. Lancet 1976; 2: 337-339 [PMID: 60569]
9. Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K, Matsuura M, Ito Y, Akiyama F, Sakamoto G. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol 2008; 26: 3727-3734 [PMID: 18669459 DOI: 10.1200/jco.2007.14.2968]
10. Park SK, Andreotti G, Sakoda LC, Gao YT, Rashid A, Chen J, Chen BE, Rosenberg PS, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Chanock S, Hsing AW. Variants in hormone-related genes and the risk of biliary tract cancers and stones: a populationbased study in China. Carcinogenesis 2009; 30: 606-614 [PMID: 19168589 DOI: 10.1093/carcin/bgp024]
11. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH, Pestell RG, Kushner PJ. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002; 277: 24353-24360 [PMID: 11986316 DOI: 10.1074/jbc.M201829200]
12. Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF, Zhang X, Lewis MT, Kuperwasser C. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res 2012; 72: 2705-2713 [PMID: 22467173 DOI: 10.1158/0008-5472.can-11-3287]
13. Sumi K, Matsuyama S, Kitajima Y, Miyazaki K. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer. Oncol Rep 2004; 12: 979-984 [PMID: 15492781]
14. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003; 3: 281-292 [PMID: 14993442 DOI: 10.1124/mi.3.5.281]
15. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25 [PMID: 9034784 DOI: 10.1210/edrv.18.1.0287]
16. Mancino A, Mancino MG, Glaser SS, Alpini G, Bolognese A, Izzo L, Francis H, Onori P, Franchitto A, Ginanni-Corradini S, Gaudio E, Alvaro D. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig Liver Dis 2009; 41: 156-163 [PMID: 18395502 DOI: 10.1016/j.dld.2008.02.015]
17. Mishra K, Behari A, Kapoor VK, Khan MS, Prakash S, Agrawal S. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer. J Gastroenterol Hepatol 2013; 28: 1678-1685 [PMID: 23962084 DOI: 10.1111/jgh.12343]
18. Letelier P, Garcia P, Leal P, Ili C, Buchegger K, Riquelme I, Sandoval A, Tapia O, Roa JC. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma. Appl Immunohistochem Mol Morphol 2014; 22: 530-536 [PMID: 24185122 DOI: 10.1097/PAI.0b013e3182a318a9]
19. Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Sivridis E. Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas. Eur J Surg Oncol 2003; 29: 879-883 [PMID: 14624781]
20. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 2002; 62: 4977-4984 [PMID: 12208749]
21. Losordo DW, Isner JM. Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 2001; 21: 6-12 [PMID: 11145928]
22. Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Mäkelä S, Chiappetta C, Stancel GM. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 2000; 108 Suppl 5: 785-790 [PMID: 11035983]
23. Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptordependent mechanism. J Endocrinol 2008; 196: 399-412 [PMID: 18252963 DOI: 10.1677/joe-07-0198]
24. Sun XN, Cao WG, Wang X, Wang Q, Gu BX, Yang QC, Hu JB, Liu H, Zheng S. Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma. Tumour Biol 2011; 32: 1183-1190 [PMID: 21853312 DOI: 10.1007/s13277-011-0221-2]
25. Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, Ibañez L, Pimentel F, Diaz A, Riggins GJ, Maitra A. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res 2008; 14: 2631-2638 [PMID: 18451226 DOI: 10.1158/1078-0432.ccr-07-1991]
26. Park SK, Andreotti G, Rashid A, Chen J, Rosenberg PS, Yu K, Olsen J, Gao YT, Deng J, Sakoda LC, Zhang M, Shen MC, Wang BS, Han TQ, Zhang BH, Yeager M, Chanock SJ, Hsing AW. Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis 2010; 31: 842-846 [PMID: 20172949 DOI:10.1093/carcin/bgq038]